Shantou Institute of Ultrasonic Instrument
301602
Hubei Sinophorus Electronic Materials
688545
Pansoft
300996
4
Jiayu Holding
300117
5
Wuxi Taclink Optoelectronics Technology
688205
US Stock MarketDetailed Quotes
CARM Carisma Therapeutics
- 0.456
- -0.004-0.89%
Trading Jan 22 12:36 ET
19.03MMarket Cap-0.30P/E (TTM)
0.470High0.444Low133.67KVolume0.456Open0.460Pre Close60.92KTurnover0.44%Turnover RatioLossP/E (Static)41.75MShares2.77052wk High-1.71P/B13.78MFloat Cap0.38052wk Low--Dividend TTM30.22MShs Float51.357Historical High--Div YieldTTM5.57%Amplitude0.380Historical Low0.455Avg Price1Lot Size
Carisma Therapeutics News
Carisma Therapeutics Appoints Interim VP of Finance
Express News | Carisma Therapeutics Inc: On Dec 24, Appoints Natalie Mcandrew as Principal Financial Officer
H.C. Wainwright Downgrades Carisma Therapeutics(CARM.US) to Hold Rating
Express News | HC Wainwright & Co. Downgrades CARISMA Therapeutics to Neutral
Carisma Downgraded by Baird Over Lack of Near-term Catalysts
Express News | D. Boral Capital Maintains Buy on CARISMA Therapeutics, Maintains $12 Price Target
Carisma Therapeutics Price Target Cut to $1.00/Share From $10.00 by Baird
Baird Downgrades Carisma Therapeutics(CARM.US) to Hold Rating, Cuts Target Price to $1
BTIG Maintains Carisma Therapeutics(CARM.US) With Hold Rating
Carisma Therapeutics: Hold Rating Amid Strategic Shift and Uncertain Pipeline Prospects
Express News | Carisma Therapeutics Inc : Baird Cuts to Neutral Rating; Cuts Target Price to $1 From $10
Carisma Therapeutics Cut to In-Line From Outperform by Evercore ISI Group
Carisma Therapeutics Price Target Cut to $0.70/Share From $4.00 by Evercore ISI Group
Evercore Downgrades Carisma Therapeutics(CARM.US) to Hold Rating, Cuts Target Price to $0.7
Carisma Therapeutics Cut to Neutral From Buy by BTIG
BTIG Downgrades Carisma Therapeutics(CARM.US) to Hold Rating
BTIG Downgrades Carisma Therapeutics (CARM) to a Hold
Express News | Carisma Therapeutics Inc - Chief Financial Officer, Richard Morris Will Leave Company Effective Dec 31
Express News | Carisma Therapeutics Inc -Development of Ct-0525 to Be Discontinued; Workforce Reduced by 34%
Express News | Carisma Therapeutics Announces Strategic Restructuring to Re-Prioritize Pipeline
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
December CPI comes in as expected, is that enough?
U.S. December CPI rose 2.9% year-on-year, aligning with expectations but marking a three-month inflation increase trend. The market reacted
In One Chart
Jan 15 22:05
Here's the Breakdown for December CPI, in One Chart